56966-61-1

Basic information

• Product Name: 4-Bromo-2-nitro-1-phenoxybenzene
• Synonyms: 4-Bromo-2-nitro-1-phenoxybenzene
• CAS NO: 56966-61-1
• Molecular Formula: C₁₂H₈BrNO₃
• Molecular Weight: 294.10082
• EINECS: -0
• Mol File: 56966-61-1.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 4-Bromo-2-nitro-1-phenoxybenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Bromo-2-nitro-1-phenoxybenzene(56966-61-1)
• EPA Substance Registry System: 4-Bromo-2-nitro-1-phenoxybenzene(56966-61-1)

Safety Data

• Hazardous Substances Data: 56966-61-1(Hazardous Substances Data)

Upstream product

• 3460-18-2 1,4-dibromo-2-nitrobenzene 
• 100-67-4 potassium phenolate 
• 16588-24-2 4-bromo-1-chloro-2-nitrobenzene 
• 364-73-8 4-Bromo-1-fluoro-2-nitrobenzene 
• 108-95-2 phenol 

Downstream Products

• 72405-05-1 (4-bromo-2-nitro-phenyl)-(2,4-dibromo-phenyl)-ether 
• 15211-97-9 (4-bromo-2-nitro-phenyl)-(4-bromo-phenyl)-ether 
• 56966-45-1 5-bromo-2-phenoxyaniline 
• 2217-56-3 bis(2,4-dinitrophenyl) ether 
• 909109-24-6 N-(5-bromo-2-phenoxyphenyl)-N-(2,5-dimethoxybenzyl)acetamide 
• 1041518-56-2 5-bromo-2-(4-bromo-phenoxy)-aniline 
• 72405-09-5 5-bromo-2-(2,4-dibromo-phenoxy)-aniline 
• 873980-49-5 4,5-dibromo-2-(4-bromo-phenoxy)-aniline 
• 860577-30-6 acetic acid-[5-bromo-2-(4-bromo-phenoxy)-anilide] 
• 873386-10-8 acetic acid-[4,5-dibromo-2-(4-bromo-phenoxy)-anilide] 
• 873977-98-1 acetic acid-[5-bromo-2-(2,4-dibromo-phenoxy)-anilide] 
• 364353-92-4 2-phenoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolane-2-yl)benzonitrile 
• 1644527-01-4 N--(2,5-dimethoxybenzyl)-N--(2--phenoxy--5-(4,4,5,5-tetramethyl-1,3,2--dioxaborolan-2-yl)phenyl)acetamide 

Relevant articles and documents

Enhanced copper-mediated 18F-fluorination of aryl boronic esters provides eight radiotracers for PET applications

[18F]FMTEB, [18F]FPEB, [18F]flumazenil, [18F]DAA1106, [18F]MFBG, [18F]FDOPA, [18F]FMT and [18F]FDA are prepared from the corresponding arylboronic esters and [18

NON-STEROIDAL PROGESTERONE RECEPTOR MODULATORS

The present invention provides compounds according to general Formula (I), a prodrug thereof, a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable salt of a prodrug thereof. More particularly, the present invention provides high affinity non-steroidal compounds which are agonists, partial agonists or antagonists of the progesterone receptor.